Treatment by HIFU With Focal One® of Posterior Deep Infiltrating Endometriosis Lesions With Intestinal Involvement.

计划入组 20 人 · 首次发布于 2018 年 8 月 3 日

Evaluation of Focal Treatments of Localized Prostate Cancers With High Intensity Focused Ultrasound Using the Focal One® Device

计划入组 39 人 · 首次发布于 2016 年 1 月 25 日

Clinical Data Collection of Patients Treated With High Intensity Focused Ultrasound (HIFU) by the Focal One for Their Prostate Cancer.

计划入组 3,000 人 · 首次发布于 2026 年 6 月 12 日

focal adhesion kinase

renal therapeutic (focal segmental glomerulosclerosis)

ONE-001

ONE HEART WORLDWIDE

United States

Day One Biopharmaceuticals

United States

Oxygen One, Inc.

United States

EDAP Reports Record HIFU Revenue in Q4 2025, FDA-Cleared Next-Gen Focal One Platform Drives 34% Growth

EDAP TMS Announces First Patients Treated in Phase I/II Study of Focal One HIFU for Benign Prostatic Hyperplasia

EDAP and Telix Partner to Advance Precision Prostate Cancer Treatment Through HIFU-PSMA PET Integration